Bladder Cancer
Research activity is centered on urothelial malignancy, with particular attention to muscle-invasive bladder cancer and patients who are not candidates for standard platinum-based chemotherapy.
- Perioperative treatment
- Muscle-invasive bladder cancer
- Urothelial carcinoma
- Cisplatin-ineligible patients
The sponsor’s clinical interest includes bladder cancer immunotherapy and treatment strategies aimed at improving surgical outcomes in the perioperative setting.
